Literature DB >> 31353533

Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observations.

Carlos Cepeda1, Katerina D Oikonomou1, Damian Cummings1, Joshua Barry1, Vannah-Wila Yazon1, Dickson T Chen1, Janelle Asai1, Christopher K Williams2,3, Harry V Vinters2,3.   

Abstract

Huntington's disease (HD), an inherited neurodegenerative disorder that principally affects striatum and cerebral cortex, is generally thought to have an adult onset. However, a small percentage of cases develop symptoms before 20 years of age. This juvenile variant suggests that brain development may be altered in HD. Indeed, recent evidence supports an important role of normal huntingtin during embryonic brain development and mutations in this protein cause cortical abnormalities. Functional studies also demonstrated that the cerebral cortex becomes hyperexcitable with disease progression. In this review, we examine clinical and experimental evidence that cortical development is altered in HD. We also provide preliminary evidence that cortical pyramidal neurons from R6/2 mice, a model of juvenile HD, are hyperexcitable and display dysmorphic processes as early as postnatal day 7. Further, some symptomatic mice present with anatomical abnormalities reminiscent of human focal cortical dysplasia, which could explain the occurrence of epileptic seizures in this genetic mouse model and in children with juvenile HD. Finally, we discuss recent treatments aimed at correcting abnormal brain development.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Huntington's disease; cortical development; cortical dysplasia; electrophysiology; epilepsy

Year:  2019        PMID: 31353533      PMCID: PMC6801077          DOI: 10.1002/jnr.24503

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  101 in total

1.  Intracortical inhibition and facilitation are abnormal in Huntington's disease: a paired magnetic stimulation study.

Authors:  G Abbruzzese; A Buccolieri; R Marchese; C Trompetto; P Mandich; M Schieppati
Journal:  Neurosci Lett       Date:  1997-06-06       Impact factor: 3.046

2.  Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice.

Authors:  Edward C Stack; Alpaslan Dedeoglu; Karen M Smith; Kerry Cormier; James K Kubilus; Mikhail Bogdanov; Wayne R Matson; Lichuan Yang; Bruce G Jenkins; Ruth Luthi-Carter; Neil W Kowall; Steven M Hersch; M Flint Beal; Robert J Ferrante
Journal:  J Neurosci       Date:  2007-11-21       Impact factor: 6.167

3.  CAG repeat number governs the development rate of pathology in Huntington's disease.

Authors:  J B Penney; J P Vonsattel; M E MacDonald; J F Gusella; R H Myers
Journal:  Ann Neurol       Date:  1997-05       Impact factor: 10.422

Review 4.  Excitotoxic injury of the neostriatum: a model for Huntington's disease.

Authors:  M DiFiglia
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

5.  Huntington disease in children: genotype-phenotype correlation.

Authors:  A Rasmussen; R Macias; P Yescas; A Ochoa; G Davila; E Alonso
Journal:  Neuropediatrics       Date:  2000-08       Impact factor: 1.947

6.  Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease.

Authors:  E Sapp; J Penney; A Young; N Aronin; J P Vonsattel; M DiFiglia
Journal:  J Neuropathol Exp Neurol       Date:  1999-02       Impact factor: 3.685

7.  Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease.

Authors:  Ana María Estrada-Sánchez; Courtney L Burroughs; Stephen Cavaliere; Scott J Barton; Shirley Chen; X William Yang; George V Rebec
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

8.  Mutant huntingtin affects cortical progenitor cell division and development of the mouse neocortex.

Authors:  Maria Molina-Calavita; Monia Barnat; Salah Elias; Esther Aparicio; Matthieu Piel; Sandrine Humbert
Journal:  J Neurosci       Date:  2014-07-23       Impact factor: 6.167

9.  Abnormal motor cortex excitability in preclinical and very early Huntington's disease.

Authors:  Sven Schippling; Susanne A Schneider; Khailash P Bhatia; Alexander Münchau; John C Rothwell; Sarah J Tabrizi; Michael Orth
Journal:  Biol Psychiatry       Date:  2009-02-07       Impact factor: 13.382

10.  Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent.

Authors:  H Telenius; H P Kremer; J Theilmann; S E Andrew; E Almqvist; M Anvret; C Greenberg; J Greenberg; G Lucotte; F Squitieri
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

View more
  5 in total

1.  Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Authors:  Carlos Cepeda; Michael S Levine
Journal:  Neuroscientist       Date:  2020-11-16       Impact factor: 7.235

Review 2.  Juvenile-Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review.

Authors:  Hannah S Bakels; Raymund A C Roos; Willeke M C van Roon-Mom; Susanne T de Bot
Journal:  Mov Disord       Date:  2021-10-12       Impact factor: 9.698

3.  Cortical Features in Child and Adolescent Carriers of Mutant Huntingtin (mHTT).

Authors:  Erin E Reasoner; Ellen van der Plas; Douglas R Langbehn; Amy L Conrad; Timothy R Koscik; Eric A Epping; Vincent A Magnotta; Peggy C Nopoulos
Journal:  J Huntingtons Dis       Date:  2022

Review 4.  Synaptic pathology in Huntington's disease: Beyond the corticostriatal pathway.

Authors:  Joshua Barry; Minh T N Bui; Michael S Levine; Carlos Cepeda
Journal:  Neurobiol Dis       Date:  2021-11-27       Impact factor: 7.046

Review 5.  The Neurodevelopmental Hypothesis of Huntington's Disease.

Authors:  Ellen van der Plas; Jordan L Schultz; Peg C Nopoulos
Journal:  J Huntingtons Dis       Date:  2020
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.